抗体生産の世界市場：抗体生産装置（バイオリアクター、遠心機、限外ろ過装置）、抗体生産消耗品、モノクローナル抗体、ポリクローナル抗体...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 19)
2.1.1 Research Methodology Steps
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.3 Key Data From Secondary Sources
2.1.3.1 Primary Research
2.1.3.2 Key Industry Insights
2.1.4 Key Data From Primary Sources
2.1.5 Key Insights From Primary Sources
2.1.6 Market Size Estimation Methodology
2.1.7 Market Forecast Methodology
2.1.8 Market Data Validation and Triangulation
2.1.9 Assumptions for the Study

3 Executive Summary (Page No. – 30)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 36)
4.1 Global Antibody Production Market
4.2 Antibody Production Market, By Region and End User
4.3 Geographic Snapshot of the Antibody Production Market
4.4 Antibody Production Market, By Technology (2014 vs. 2019)

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Global Demand for Monoclonal Antibodies (MABS)
5.3.1.2 Rising R&D Expenditure of Pharmaceutical and Biotechnology Companies
5.3.2 Challenges
5.3.2.1 High Cost of Primary Antibodies
5.3.3 Opportunities
5.3.3.1 Emerging Markets of India and China
5.3.3.2 Rising Demand for Protein Therapeutics
5.3.3.1 Increasing Risk of Infectious Diseases

6 Industry Trends (Page No. – 49)
6.1 Supply Chain Analysis
6.1.1 Prominent Companies
6.1.2 Small and Medium Enterprises
6.1.3 End Users
6.1.4 Key Influencers
6.1.4.1 Investors, Venture Capitalists, and Funding Bodies
6.1.4.2 Regulatory Bodies
6.1.4.3 Academic Researchers/Organizations
6.2 Pest Analysis
6.2.1 Political Factors
6.2.2 Economic Factors
6.2.3 Social Factors
6.2.4 Technological Factors

7 Antibody Production Market, By Product (Page No. – 53)
7.1 Introduction
7.2 Equipment
7.2.1 Bioreactors
7.2.2 Centrifuges
7.2.3 Ultrafiltration Systems
7.2.4 Other Equipment
7.3 Consumables
7.3.1 Sera
7.3.2 Media
7.3.3 Reagents and Buffers
7.3.4 Chromatography Resins and Columns

8 Antibody Production Market, By Type (Page No. – 61)
8.1 Introduction
8.2 Monoclonal Antibodies
8.3 Polyclonal Antibodies

9 Global Antibody Production Market, By Technology (Page No. – 67)
9.1 Introduction
9.1.1 Hybridoma Technology
9.1.2 Hybridoma-Free Technology

10 Antibody Production Market, By End User (Page No. – 71)
10.1 Introduction
10.1.1 Pharmaceutical and Biotechnology Companies
10.1.2 Diagnostic Laboratories
10.1.3 Research Institutes

11 Antibody Production Market, By Region (Page No. – 77)

12 Competitive Landscape (Page No. – 123)
12.1 Overview
12.2 Market Share Analysis, Antibody Production Market
12.2.1 Ge Healthcare
12.2.2 Thermo Fisher Scientific, Inc.
12.2.3 Sartorius AG
12.3 Competitive Situation and Trends
12.3.1 Agreements/Partnerships/Joint Ventures/Collaborations
12.3.2 Expansions
12.3.3 New Product Launches
12.3.4 Acquisitions
12.3.5 Others

13 Company Profiles (Page No. – 134)
13.1 Introduction
13.2 Ge Healthcare
13.2.1 Business Overview
13.2.2 Product Portfolio
13.2.3 Key Strategies
13.2.4 Recent Developments
13.3 Thermo Fisher Scientific, Inc.
13.3.1 Business Overview
13.3.2 Product Portfolio
13.3.3 Key Strategies
13.3.4 Recent Developments
13.4 Sartorius AG
13.4.1 Business Overview
13.4.2 Products & Services
13.4.3 Key Strategy
13.4.4 Recent Developments
13.5 Merck Millipore
13.5.1 Business Overview
13.5.2 Product Portfolio
13.5.3 Key Strategy
13.5.4 Recent Developments
13.6 Sigma-Aldrich Corporation
13.6.1 Business Overview
13.6.2 Product Portfolio
13.6.3 Key Strategy
13.6.4 Recent Developments
13.7 Abcam PLC
13.7.1 Business Overview
13.7.2 Product Portfolio
13.7.3 Key Strategies
13.7.4 Recent Developments
13.8 Roche Applied Science
13.8.1 Business Overview
13.8.2 Product Portfolio
13.8.3 Key Strategy
13.8.4 Recent Developments
13.9 Amgen, Inc.
13.9.1 Business Overview
13.9.2 Product Portfolio
13.9.3 Key Strategies
13.9.4 Recent Developments
13.10 Sanofi S. A.
13.10.1 Business Overview
13.10.2 Product Portfolio
13.10.3 Key Strategies
13.10.4 Recent Developments
13.11 Rockland Immunochemicals, Inc.
13.11.1 Business Overview
13.11.2 Product Portfolio
13.11.3 Key Strategy
13.11.4 Recent Developments

14 Appendix (Page No. – 170)
14.1 Discussion Guide
14.2 Company Developments (2012–2014)
14.2.1 Ge Healthcare
14.2.2 Thermo Fisher Scientific, Inc.
14.2.3 Sartorius AG
14.2.4 Merck Millipore
14.2.5 Sigma-Aldrich Corporation
14.2.6 Roche Applied Science
14.2.7 Amgen, Inc.
14.3 Introducing RT: Real-Time Market Intelligence
14.4 Available Customizations
14.5 Related Reports